Capital Bluecross policy updates
Track new and updated Capital Bluecross policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Allergy Testing and Immunotherapy | Capital Bluecross | Clinical | Allergy/Clinical Immunology | Modified | Jul 1, 2026 |
| Genotyping for 9p21 Single Nucleotide Polymorphisms | Capital Bluecross | Clinical | Cardiology | Modified | Jul 1, 2026 |
| Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures) | Capital Bluecross | Clinical | Cardiology | Modified | Jul 1, 2026 |
| Closure Devices for Patent Foramen Ovale (PFO) and Atrial Septal Defects (ASD) | Capital Bluecross | Clinical | Cardiology | Modified | Jul 1, 2026 |
| Temporomandibular Disorder (TMD) — Coverage Criteria | Capital Bluecross | Clinical | Dental/Oral & Maxillofacial | Modified | Jul 1, 2026 |
| Confocal Laser Endomicroscopy | Capital Bluecross | Clinical | Gastroenterology | Modified | Jul 1, 2026 |
| Esophagogastroduodenoscopy (EGD) | Capital Bluecross | Clinical | Gastroenterology | Modified | Jul 1, 2026 |
| Genetic Testing for Familial Cutaneous Malignant Melanoma (CDKN2A, CDK4) | Capital Bluecross | Clinical | Genetic & Molecular Testing | Modified | Jul 1, 2026 |
| Gene expression–based assays for cancers of unknown primary (CUP) | Capital Bluecross | Clinical | Genetic & Molecular Testing | Modified | Jul 1, 2026 |
| Genetic testing for heterozygous familial hypercholesterolemia (FH) | Capital Bluecross | Clinical | Genetic & Molecular Testing | Modified | Jul 1, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.